Regenexx Corporate Overview Webinar for Alliant Clients

We’re holding five sessions. Select the date & time that is the most convenient for you.

Why Join Us?

Orthopedic diseases cost $980 billion annually and typically make up 20% of health plan spending. Alliant partner, Regenexx, has created a new medical specialty, Interventional Orthopedics. Using precise image-guided injections of orthobiologics, this treatment replaces the need for up to 70% of elective orthopedic surgeries and saves self-funded plans up to 70% compared to individual orthopedic surgeries.

During this 45 minute webinar, Jason Hellickson, of Regenexx Corporate, will join us in hosting a webinar for the Alliant team that walks through the Regenexx cost-savings program for self-funded employers. Key learning objectives are outlined below.

Topics to be covered in this webinar:

1. Understand the current state of musculoskeletal care and the costs involved.
2. Distinguish between orthopedic surgery and interventional orthopedics.
3. Identify the key issues a fiduciary must consider when deciding on adding an intervention to a health plan.
4. Learn about the communication strategies that help create employee engagement.